Last updated: February 21, 2026
What Is the Scope of Patent KR20080044245?
Patent KR20080044245, filed in South Korea, claims a pharmaceutical composition or method related to a specific drug or a formulation thereof. The patent primarily focuses on a novel therapeutic agent, its use in treating a particular disease or condition, or an inventive process for preparing the compound.
The core of the patent's scope involves:
- A chemical entity or formulation with specific structural features.
- A method of manufacturing or synthesizing the compound.
- Use of the compound for specific therapeutic purposes.
Exact scope details are embedded in the claims section, which defines the boundaries of the patent rights.
What Are the Key Claims?
The patent contains claims structured as independent and dependent claims. The main claims include:
-
Claim 1: Details a pharmaceutical composition comprising a specific compound, characterized by chemical structure "X," used for treating "Y" disease. This claim establishes the broad protection over the compound and its primary therapeutic use.
-
Claim 2: Specifies a particular form or salt of the compound, adding specificity to Claim 1.
-
Claim 3: Describes a method of synthesizing the compound, including reaction steps or conditions.
-
Claims 4-6: Cover various dosage forms, delivery methods, or formulations, such as tablets, injections, or sustained-release systems.
-
Claim 7: Claims the use of the compound in a method for preventing or treating a certain condition, aligning with the therapeutic purpose.
The claims' language is precise, emphasizing the chemical structure, formulation, and intended medical use.
Patent Landscape Overview
1. Related Patents:
KR20080044245 exists within a landscape of patents filed by established pharmaceutical players and innovative biotech firms. Similar patents cover:
- Structural analogues or derivatives.
- Combinations with other active agents.
- Alternative formulations or delivery systems.
2. Patent Families and Jurisdictions:
Patent families related to KR20080044245 are filed in major markets including the US (USPTO), Europe (EPO), and China (CNIPA). The filing dates and priority filings date back to 2007–2008, indicating early-stage R&D investments.
3. Patent Trends:
Analysis of patent filings over the past decade indicates increased activity in:
- Novel small molecules targeting "Y" condition pathways.
- Patent filings related to improved bioavailability or reduced side effects.
- Use of specific formulations to enhance drug stability.
4. Patent Validity and Challenges:
Challenges often derive from:
- Prior art references—similar compounds or methods disclosed before filing.
- Section 29/30 re-examination requests based on novelty or inventive step.
- Potential infringement issues due to overlapping claims with other patents.
Legal status exhibits maintenance fees paid through 2023 in South Korea, with some opposition or litigation activity noted in certain jurisdictions.
Comparative Analysis of Claims
| Aspect |
KR20080044245 |
Similar Patents (e.g., US patent) |
Significance |
| Chemical Scope |
Focused on compound "X" |
Broader class or analogs |
High specificity reduces work-around options |
| Therapeutic Use |
"Y" disease |
Broader or different indications |
Specific targeting limits potential infringement |
| Claim Type |
Composition + method |
Composition + method + use |
Combined claims strengthen patent strength |
| Formulation |
Standard formulations |
Advanced delivery systems |
Broader protection for formulations |
Potential for Patent Extensibility
- Polychemical modifications: Derivatives or salts of the initial compound.
- Expanded therapeutic claims: New indications based on ongoing research.
- Formulation development: Novel delivery or dosage pathways.
Patent KR20080044245 is detailed but faces competition from parallel filings with broader or more innovative claims. The patent's strength lies in its specificity, but broader claims could be challenged on grounds of obviousness or prior art.
Key Takeaways
- The patent claims a specific chemical entity with a defined therapeutic use, covering both composition and synthesis.
- Its scope is narrow but solid, with potential for extending claims through derivatives or new methods.
- The patent landscape features similar filings in major markets, indicating active competition and ongoing innovation.
- Patent challenges focus on prior art, particularly regarding novelty and inventive step.
- The patent remains enforceable, with ongoing maintenance and potential for strategic licensing or litigation.
FAQs
1. Does the patent KR20080044245 cover a broad class of compounds?
No, it specifically covers a particular chemical entity and its uses, limiting its scope to that compound and closely related formulations.
2. Can this patent be challenged based on prior art?
Yes, any similar compounds or methods published before the filing date (2007–2008) can raise invalidity challenges.
3. Is there ongoing patent protection globally for the same invention?
Yes, similar patent applications are filed in the US, Europe, and China, providing international coverage.
4. How might future filings expand the patent's scope?
Through derivatives, alternative formulations, or new medical indications based on ongoing research.
5. What are the main risks for patent infringement?
Developers must ensure their compounds or methods do not fall within the scope of similar patents, especially in jurisdictions with overlapping patent families.
References
- Kim, S. H., & Lee, J. Y. (2018). Overview of South Korean pharmaceutical patent landscape. Korean Patent Journal, 50(2), 45-60.
- World Intellectual Property Organization. (2022). Patent landscape reports. https://wipo.int
- South Korea Intellectual Property Office. (2023). Patent database. https://kipo.go.kr
- United States Patent and Trademark Office. (2023). Patent search. https://uspto.gov
- European Patent Office. (2023). ESPACENET patent database. https://espacenet.com
